출판：BCC Research 출판년월：2022년12월
Continuous Glucose Monitoring (CGM): Technologies and Global Markets
이 연구의 범위는 포도당 모니터링, 연결된 펌프 및 펜, SMBG 미터 및 테스트 스트립에 대한 현재 및 예측 시장을 포함합니다.
| 페이지수 | 123 |
| 가격 | |
| Single User License | USD 5,500 |
| 2-5 User License | USD 6,600 |
| Site License | USD 7,920 |
| Enterprise License | USD 9,504 |
| 구성 | 영문조사보고서 |
Report Highlights
The global CGM market should reach $20.7 billion by 2022 and $32.7 billion by 2027, with a compound annual growth rate (CAGR) of 9.5% during the forecast period of 2022-2027.
글로벌 CGM 시장은 2022년까지 207억 달러, 2027년까지 327억 달러에 이를 것으로 예상되며, 2022-2027년 예측 기간 동안 연평균 성장률(CAGR)은 9.5%입니다.
Reasons for Doing This Study:
This study provided detailed information regarding developments in continuous glucose monitoring. The incidence of Type 2 diabetes continues to increase in developed and developing countries, driven by the rise in obesity. Continuous glucose monitoring (CGM) is designed to provide a more accurate way to monitor blood glucose levels, allowing diabetic patients to regulate blood glucose better, decrease the risk of diabetes-related damage to their bodies and ultimately improve their health and decrease healthcare costs.
This BCC Research market research report will increase the awareness of current and developing technologies affecting continuous glucose monitoring devices and markets.
Report Scope:
The scope of this study encompasses the current and forecast markets for glucose monitoring, connected pumps and pens, SMBG meters, and test strips. The covered segments are CGM transmitters, receivers and sensors, smart pumps and pens, and self-monitoring blood glucose (SMBG) equipment and test strips. The test strip market numbers refer to all types of test strips with SMBG, and not just test strips as used by CGM users. CGM users also use test strips, but theoretically only for calibrating their CGM devices. The report also includes discussions of the market opportunities, patent scenario, market projections and market shares, competitive landscape, and the key company profiles. The report would also cover the COVID-19 impact on the CGM market.
Report Includes:
– 27 data tables and 28 additional tables
– A detailed overview and an up-to-date analysis of the global markets for continuous glucose monitoring (CGM) devices and technologies
– Analyses of the global market trends, with historic market revenue (sales figures) for 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
– Highlights of market opportunities for this innovation-driven continuous glucose monitoring devices market, and the major regions and countries involved in market developments
– Estimation of the actual market size and revenue forecast for CGM devices in USD million values, and corresponding market share analysis by technology type, end-user settings, type of diabetes, user age group, and region
– Country specific data and market value analysis for the United States, Canada, Germany, U.K., France, Italy, Japan, China, South Korea, etc.
– Reassessment of the critical issues surrounding CGM transmitters/receivers, self-monitoring blood glucose (SMBG) equipment and test strips, and durable insulin pumps; their recent technological advancements, geographic trends, market dynamics, and adoption trends
– Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performance, and segmental revenues
– Review of the key patent grants and patent applications within select CGM technologies
– Company profiles of major players within the industry, including Abbott Laboratories, F. Hoffmann-La Roche, Medtronic PLC, Novo Nordisk, and Sanofi S.A.
목차
Table of Contents
1.1 Chapter 1 Introduction
1.2 Study Goals and Objectives
1.3 Reasons for Doing This Study
1.4 Scope of Report
1.5 What’s New in This Update?
1.6 Information Sources
1.7 Research Methodology
1.8 Geographic Breakdown
1.9 Analyst’s Credentials
1.10 BCC Custom Research
1.11 Related BCC Research Reports
Chapter 2 Summary and Highlights
2.1 Highlights of the Market for CGM Devices
Chapter 3 Market and Technology Background
3.1 Diabetes
3.1.1 Types of Diabetes Mellitus
3.1.2 Diabetes Diagnosis
3.1.3 Diabetes Prevalence and Global Economic Burden
3.1.4 Treatment of Diabetes
3.1.5 Importance of Glucose Monitoring in Diabetes
3.1.6 SMBG Devices
3.1.7 Noninvasive Blood Glucose Monitoring
3.1.8 Continuous Glucose Monitoring (CGM)
3.1.9 Working to Improve CGM Technology
Chapter 4 Market Breakdown by Technology Type
4.1 Global Market for Continuous Glucose Monitoring (CGM) Devices
4.2 Global CGM Markets
4.3 Global Smart Insulin Pumps and Pens Markets
4.4 Global SMBG Meters and Test Strips Markets
Chapter 5 Market Breakdown by End-User Settings
5.1 CGM Market, by End-User Settings
5.2 CGM Market for Home Use
5.3 Hospital and Clinics
5.4 Others
Chapter 6 CGM Market by Type of Diabetes
6.1 CGM Markets, by Type of Diabetes
6.2 Type 1 Diabetes
6.3 Type 2 Diabetes
6.4 Gestational Diabetes
6.5 Others
Chapter 7 CGM Markets, by User’s Age
7.1 CGM Markets, by User’s Age
7.2 Children
7.3 Teenagers
7.4 Youth
7.5 Middle-Aged
7.6 Aged
Chapter 8 Market Breakdown by Region
8.1 North America
8.1.1 U.S
8.1.2 Canada
8.2 Europe
8.2.1 Germany
8.2.2 The UK
8.2.3 France
8.2.4 Italy
8.2.5 Rest of Europe
8.3 Asia-Pacific
8.3.1 China
8.3.2 Japan
8.3.3 South Korea
8.3.4 Rest of Asia-Pacific
8.4 Rest of the World
Chapter 9 Patent Review
9.1 Patent Review
Chapter 10 Competitive Landscape
10.1 Market Share Analysis
Chapter 11 COVID-19 Impact on the CGM Market
11.1 COVID-19 Impact on the CGM Market
Chapter 12 Analysis of the Market Opportunities
Chapter 13 Company Profiles
13.1 Major Companies
ABBOTT LABORATORIES
BETA BIONICS, INC.
BIGFOOT BIOMEDICAL
DEXCOM INC.
F. HOFFMANN-LA ROCHE LTD.
INSULET CORP.
LIFESCAN IP HOLDINGS, LLC
MEDTRONIC PLC
NOVO NORDISK A/S
PKVITALITY
SANOFI S.A.
SENSEONICS HOLDINGS INC.
TANDEM DIABETES CARE
YPSOMED AG
13.2 Other Companies
ASCENSIA DIABETES CARE HOLDINGS AG
EMPERRA GMBH E-HEALTH TECHNOLOGIES
GLUCOTRACK, INC.
INTUITY MEDICAL INC.
NEMAURA MEDICAL INC.
NOVIOSENSE BV
QLIBRIUM
SINOCARE INC.
List of Tables
Summary Table : Global Market for CGM, by Technology Type, Through 2027
Table 1 : Top 15 Countries with High Prevalence of Diabetes, 2021
Table 2 : Selected Companies Developing Noninvasive Blood Glucose Monitoring Devices
Table 3 : The Key Approved CGM Devices
Table 4 : Global Market for CGM Devices, by Type, Through 2027
Table 5 : Global Market for CGM, by Region, Through 2027
Table 6 : Global Market for CGM Transmitters and Receivers, and Sensors, Through 2027
Table 7 : Global Market for Smart Insulin Pumps and Pens, by Region, Through 2027
Table 8 : Global Market for Smart Insulin Pumps and Pens, by Type, Through 2027
Table 9 : Global Market for SMBG Equipment, by Region, Through 2027
Table 10 : Global Market for SMBG Meters and Test Strips, by Type, Through 2027
Table 11 : Global Market for CGM, by End-User Settings, Through 2027
Table 12 : Global Market for CGM in Home Use, by Region, Through 2027
Table 13 : Global Market for CGM in Hospitals and Clinics, by Region, Through 2027
Table 14 : Global Market for CGM in Other Settings, by Region, Through 2027
Table 15 : Global Market for CGM, by Diabetes Type, Through 2027
Table 16 : Global Market for CGM in Type 1 Diabetes, by Region, Through 2027
Table 17 : Global Market for CGM in Type 2 Diabetes, by Region, Through 2027
Table 18 : Global Market for CGM in Gestational Diabetes, by Region, Through 2027
Table 19 : Global Market for CGM in Other Conditions, by Region, Through 2027
Table 20 : Global Market for CGM, by User’s Age, Through 2027
Table 21 : Global Market for CGM in Children, by Region, Through 2027
Table 22 : Global Market for CGM in Teenagers, by Region, Through 2027
Table 23 : Global Market for CGM in Youth, by Region, Through 2027
Table 24 : Global Market for CGM in Middle-Aged, by Region, Through 2027
Table 25 : Global Market for CGM in Aged, by Region, Through 2027
Table 26 : Global Market for CGM, by Region, Through 2027
Table 27 : North American Market for CGM, Through 2027
Table 28 : European Market for CGM, by Country, Through 2027
Table 29 : Asia-Pacific Market for CGM, by Country, Through 2027
Table 30 : Patent Record and Key Patent Areas of Applicants, 2019-2022
Table 31 : Abbott Laboratories.: CGM Products
Table 32 : Abbott Laboratories: Key Development
Table 33 : Beta Bionics, Inc.: Key Developments
Table 34 : Dexcom Inc.: CGM Products
Table 35 : Dexcom Inc.: Key Development
Table 36 : F. Hoffmann-La Roche: Product Portfolio
Table 37 : F. Hoffmann-La Roche: Key Developments
Table 38 : Insulet Corp.: CGM Products
Table 39 : Insulet Corp.: Key Developments
Table 40 : Lifescan IP Holdings, LLC.: CGM Products
Table 41 : Lifescan IP Holdings, LLC: Key Developments
Table 42 : Medtronic PLC.: CGM Products
Table 43 : Medtronic PLC: Key Developments
Table 44 : Novo Nordisk: Products Portfolio
Table 45 : Novo Nordisk: Key Developments
Table 46 : PKvitality: Key Developments
Table 47 : Sanofi S.A.: Products Portfolio
Table 48 : Sanofi S.A.: Key Developments
Table 49 : Senseonics Holdings, Inc.: Products Portfolio
Table 50 : Senseonics Holdings, Inc.: Key Developments
Table 51 : Tandem Diabetes Care: CGM Products
Table 52 : Tandem Diabetes Care: Key Developments
Table 53 : Ypsomed AG: CGM Products
Table 54 : Ypsomed AG: Key Developments
List of Figures
Summary Figure : Global Market for CGM, by Technology Type, 2019-2027
Figure 1 : Global Diabetic Population, by Region, 2021
Figure 2 : Global Market Shares of CGM Devices, by Type, 2021
Figure 3 : Global Market for CGM, by Region, 2019-2027
Figure 4 : Global Market Shares of CGM Transmitters and Receivers, and Sensors, by Type, 2021
Figure 5 : Advantages of Connected Insulin Delivery Systems
Figure 6 : Global Market for Smart Insulin Pumps and Pens, by Region, 2019-2027
Figure 7 : Global Market Shares of Smart Insulin Pumps and Pens, by Type, 2021
Figure 8 : Global Market for SMBG Equipment, by Region, 2019-2027
Figure 9 : Global Market Shares of SMBG Meters and Test Strips, by Type, 2021
Figure 10 : Global Market Shares of CGM, by End-User Settings, 2021
Figure 11 : Global Market for CGM in Home Use, by Region, 2019-2027
Figure 12 : Global Market for CGM in Hospitals and Clinics, by Region, 2019-2027
Figure 13 : Global Market for CGM in Other Settings, by Region, 2019-2027
Figure 14 : Global Market Shares of CGM, by Diabetes Type, 2021
Figure 15 : Global Market for CGM, by Diabetes Type, 2019-2027
Figure 16 : Global Market for CGM in Type 1 Diabetes, 2019-2027
Figure 17 : Global Market for CGM in Type 2 Diabetes, 2019-2027
Figure 18 : Global Market for CGM in Gestational Diabetes, 2019-2027
Figure 19 : Global Market for CGM in Other Conditions, 2019-2027
Figure 20 : Various Barriers to CGMs Usage, by User’s Age
Figure 21 : Global Market Shares of CGM, by User’s Age, 2021
Figure 22 : Global Market for CGM in Children, 2019-2027
Figure 23 : Global Market for CGM in Teenagers, 2019-2027
Figure 24 : Global Market for CGM in Youth, 2019-2027
Figure 25 : Global Market for CGM in Middle-Aged, 2019-2027
Figure 26 : Global Market for CGM in Aged, 2019-2027
Figure 27 : Snapshot of Global Market for Continuous Glucose Monitoring, by Region
Figure 28 : Global Market Shares of CGM, by Region, 2021
Figure 29 : U.S. Diabetes Prevalence Statistics
Figure 30 : U.S. Market for CGM, 2019-2027
Figure 31 : Canadian Market for CGM, 2019-2027
Figure 32 : European Market Shares of CGM, by Country, 2021
Figure 33 : German Market for CGM, 2019-2027
Figure 34 : The UK Market for CGM, 2019-2027
Figure 35 : French Market for CGM, 2019-2027
Figure 36 : Italy Market for CGM, 2019-2027
Figure 37 : Rest of European Market for CGM, 2019-2027
Figure 38 : Asia-Pacific Market Shares of CGM, by Country, 2021
Figure 39 : Chinese Market for CGM, 2019-2027
Figure 40 : Japanese Market for CGM, 2019-2027
Figure 41 : South Korean Market for CGM, 2019-2027
Figure 42 : Rest of Asia-Pacific Market for CGM, 2019-2027
Figure 43 : Rest of the World Market for CGM, 2019-2027
Figure 44 : CGM Patent Filings, by Year, 2019-2022
Figure 45 : CGM Patent Filings, by Jurisdiction, 2019-2022
Figure 46 : Patent Filings Shares, by Applicants, 2019-2022
Figure 47 : Global Company Market Shares of CGM Manufacturers, 2021
Figure 48 : CGM Market Opportunity Analysis Overview
Figure 49 : Abbott Laboratories: Annual Revenue, 2019-2021
Figure 50 : Abbott Laboratories: Market Shares, by Business Segment, 2021
Figure 51 : Abbott Laboratories: Market Shares, by Region, 2021
Figure 52 : Dexcom Inc.: Annual Revenue, 2019-2021
Figure 53 : Dexcom Inc.: Market Shares, by Region, 2021
Figure 54 : F. Hoffmann-La Roche: Annual Revenue, 2019-2021
Figure 55 : F. Hoffmann-La Roche: Revenue Share, by Division, 2021
Figure 56 : Insulet Corp.: Annual Revenue, 2020 and 2021
Figure 57 : Insulet Corp.: Market Shares of OmniPod, by Region, 2021
Figure 58 : Medtronic PLC: Annual Revenue, 2019-2021
Figure 59 : Medtronic PLC: Market Shares, by Region, 2021
Figure 60 : Medtronic PLC: Market Shares, by Business Segment, 2021
Figure 61 : Novo Nordisk: Annual Revenue, 2019-2021
Figure 62 : Novo Nordisk: Revenue Share, by Business Segment, 2021
Figure 63 : Sanofi S.A.: Annual Revenue, 2019-2021
Figure 64 : Sanofi S.A.: Revenue Share, by Business Unit, 2021
Figure 65 : Senseonics Holdings, Inc.: Annual Revenue, 2020 and 2021
Figure 66 : Tandem Diabetes Care: Annual Revenue, 2019-2021
Figure 67 : Tandem Diabetes Care: Market Shares, by Region, 2021
Figure 68 : Tandem Diabetes Care: Market Shares, by Business Segment, 2021
Figure 69 : Ypsomed AG: Annual Revenue, 2020 and 2021
Figure 70 : Ypsomed AG: Market Shares, by Region, 2021
Figure 71 : Ypsomed AG: Market Shares, by Business Segment, 2021
